U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
143431143431Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting ConditionsCompletedHas ResultsHealthyDrug: Zolpidem Tartrate 10 mg tablet|Drug: Zolpidem Tartrate 10 mg tablet (Ambien®)https://ClinicalTrials.gov/show/NCT00684814
143432143432Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNo Results AvailableColorectal Cancer|Lung Cancer|Ovarian Cancer|Pancreatic CancerOther: questionnaire administration|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00684801
143433143433Employment-Based Depot Naltrexone Clinical TrialRecruitingNo Results AvailableOpiate DependenceBehavioral: Contingency managementhttps://ClinicalTrials.gov/show/NCT00684788
143434143434Employment-Based Depot Naltrexone Clinical Trial IINot yet recruitingNo Results AvailableOpiate DependenceBehavioral: employment-based reinforcementhttps://ClinicalTrials.gov/show/NCT00684775
143435143435Fasted Bioavailability Study of Cilostazol Tablets, 100 mgCompletedHas ResultsTherapeutic EquivalencyDrug: Cilostazol 100 mg Tablets|Drug: Cilostazol (Pletal®) 100 mg Tabletshttps://ClinicalTrials.gov/show/NCT00684762
143436143436A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation MammaplastyCompletedHas ResultsBreast Augmentation|Breast Reconstructionhttps://ClinicalTrials.gov/show/NCT00684749
143437143437Tryptophan, Serotonin and Kynurenine in Septic ShockCompletedNo Results AvailableShock, Septichttps://ClinicalTrials.gov/show/NCT00684736
143438143438Fed Bioavailability Study of Lovastatin Tablets and Mevacor TabletsCompletedHas ResultsHealthyDrug: Lovastatin 40 mg Tablets|Drug: Lovastatin (Mevacor®) 40 mg Tabletshttps://ClinicalTrials.gov/show/NCT00684723
143439143439Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese SubjectsCompletedNo Results AvailableAlzheimer Disease|HealthyDrug: PAZ-417|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00684710
143440143440Iron Status and Myelination in Premature InfantsRecruitingNo Results AvailableNeurodevelopmental OutcomeDietary Supplement: ironhttps://ClinicalTrials.gov/show/NCT00684697
143441143441Safety and Feasibility Study of the Chartis SystemCompletedNo Results AvailableBronchoscopyDevice: Chartis Systemhttps://ClinicalTrials.gov/show/NCT00684684
143442143442Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary VaccinationCompletedHas ResultsViral Hepatitis Vaccines|Hepatitis B|Hepatitis ABiological: Twinrix|Biological: Engerix-B|Biological: Havrix|Biological: HBVAXPRO|Biological: Vaqtahttps://ClinicalTrials.gov/show/NCT00684671
143443143443TEENCOPE: An Internet Coping Skills Training Program for Teens With Type 1 DiabetesCompletedNo Results AvailableType 1 DiabetesBehavioral: TeenCope|Behavioral: Managing Diabeteshttps://ClinicalTrials.gov/show/NCT00684658
143444143444Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®CompletedHas ResultsMetastatic Renal Cell CarcinomaDrug: SUTENThttps://ClinicalTrials.gov/show/NCT00684645
143445143445A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer PatientsCompletedNo Results AvailablePain, CancerDrug: Placebo|Drug: KW-2246 (fentanyl citrate)https://ClinicalTrials.gov/show/NCT00684632
143446143446506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)CompletedNo Results AvailableT-ALL, T-NHL (Lymphoblastic)Drug: Nelarabinehttps://ClinicalTrials.gov/show/NCT00684619
143447143447Transcervical Foley Catheter With or Without Oxytocin for Induction of LaborRecruitingNo Results AvailablePregnancy|Induction of LaborDrug: Oxytocin IVhttps://ClinicalTrials.gov/show/NCT00684606
143448143448A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)CompletedHas ResultsPsoriasisDrug: Navarixin 10 mg|Other: Placebohttps://ClinicalTrials.gov/show/NCT00684593
143449143449Protocol For Collecting Data On Patients With Childhood CancerRecruitingNo Results AvailableChildhood CancerOther: Data Collectionhttps://ClinicalTrials.gov/show/NCT00684580
143450143450Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)CompletedHas ResultsGlioblastomaRadiation: Radiotherapy|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00684567
143451143451Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical TrialActive, not recruitingNo Results AvailableOpioid-Related Disorders|Heroin DependenceDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00684554
143452143452Interpretation Modification Program for Social PhobiaCompletedHas ResultsSocial Anxiety Disorder|Social PhobiaBehavioral: Interpretation Modification Program|Behavioral: Interpretation Control Conditionhttps://ClinicalTrials.gov/show/NCT00684541
143453143453A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumetâ„¢ Compared to MetforminRecruitingNo Results AvailableDiabetes Type 2Drug: Metformin 1500 mg daily|Drug: Metformin + Janufer (Janumet)https://ClinicalTrials.gov/show/NCT00684528
143454143454Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)CompletedHas ResultsCerebral InfarctionDrug: Vorapaxar 2.5 mg|Drug: Vorapaxar 1 mg|Drug: Placebo|Drug: Aspirin 75-150 mghttps://ClinicalTrials.gov/show/NCT00684515
143455143455Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy SubjectsCompletedNo Results AvailablePainDrug: AZD2066|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00684502
143456143456Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated HypertensionCompletedNo Results AvailableHypertensionDrug: clinical hypertension specialist-no specific med. Any anti-hypertension meds.|Drug: renin guided therapeutics-no specific med. Any anti-hypertensive med.https://ClinicalTrials.gov/show/NCT00684489
143457143457Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-StingsCompletedNo Results AvailableVenom AllergyDrug: venom immunotherapyhttps://ClinicalTrials.gov/show/NCT00684476
143458143458Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)CompletedNo Results AvailableNeoplasms|Nausea|VomitingDrug: Palonosetronhttps://ClinicalTrials.gov/show/NCT00684463
143459143459Cardiac Surgery: In Vivo Titration of ProtamineCompletedNo Results AvailableBleedingProcedure: Titration protamine|Drug: Standard administration of protaminehttps://ClinicalTrials.gov/show/NCT00684450
143460143460Literacy and Smoking Risk CommunicationsActive, not recruitingNo Results AvailableSmokingBehavioral: Focus Group|Behavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00684437

* Görseller ve İçerik tekif hakkına sahip olabilir